New strategies for the treatment of acute venous thromboembolism

Keyphrases

• Heparin 100%
• Low Molecular Weight Heparin 100%
• Deep Vein Thrombosis 100%
• Oral Anticoagulants 100%
• Acute Venous Thromboembolism 100%
• Patient Selection 50%
• Clinical Information 50%
• Thrombin 50%
• Long-term Treatment 50%
• Right Ventricular Function 50%
• Anticoagulants 50%
• Pulmonary Embolism 50%
• Copyright 50%
• Secondary Prevention 50%
• Elastic Stockings 50%
• Venous Thromboembolism Prevention 50%
• Thrombolytic Drugs 50%
• Factor Xa 50%
• Early Administration 50%
• Advanced Malignancies 50%
• Anticoagulant Drugs 50%
• Post-thrombotic 50%
• Fixed Dose 50%
• Provoked Venous Thromboembolism 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticoagulant Agent 100%
• Venous Thromboembolism 100%
• Low Molecular Weight Heparin 50%
• Heparin 50%
• Deep Vein Thrombosis 50%
• Fibrinolytic Agent 25%
• Thrombin 25%
• Lung Embolism 25%
• Blood Clotting Factor 10a 25%

Neuroscience

• Antithrombotic 100%
• Deep Vein Thrombosis 66%
• Low Molecular Weight Heparin 66%
• Heparin 66%
• Pulmonary Embolism 33%
• Thrombin 33%
• Blood Clotting Factor 10a 33%
• Thrombolytic Drug 33%